Home › Calculator › EYPT Dividend Calculator 2026
EYPT Dividend DRIP Calculator 2026
14.31% YieldHealthcareEyePoint Pharmaceuticals, Inc. · NASDAQ
Price: $13.98 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When EYPT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your EYPT snowball 📈
$10,000 in EYPT → $62781.39M in 10 years · $5,196,311,988.79/month
About EyePoint Pharmaceuticals, Inc. (EYPT) — Dividend Analysis 2026
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Additionally, YUTIQ50 is being advanced as a treatment for chronic non-infectious uveitis affecting the posterior region of the eye. To bolster its market reach and development efforts, the company maintains strategic alliances with entities such as Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. Furthermore, a commercial collaboration with ImprimisRx PA, Inc. specifically focuses on the joint promotion of DEXYCU for inflammation following ocular surgery. Incorporated in 1987, the organization was previously known as pSivida Corp. before officially rebranding as EyePoint Pharmaceuticals, Inc. in March 2018. Its corporate headquarters are situated in Watertown, Massachusetts.
Compare EYPT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full EYPT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EYPT position with:
🌍 EYPT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold EYPT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 14.31% | 11.51% | $1,431 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 12.16% | 9.36% | $1,216 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 11.45% | 8.65% | $1,145 / yr |
| 🇬🇧 UK ISA | 0% | 14.31% | 11.51% | $1,431 / yr |
| 🇬🇧 UK Taxable | 8.75% | 13.06% | 10.26% | $1,306 / yr |
| 🇨🇦 TFSA | 0% | 14.31% | 11.51% | $1,431 / yr |
| 🇨🇦 CA Taxable | 25% | 10.73% | 7.93% | $1,073 / yr |
| 🇦🇺 Super (pension) | 15% | 12.16% | 9.36% | $1,216 / yr |
| 🇦🇺 AU Taxable | 30% | 10.02% | 7.22% | $1,002 / yr |
| 🇩🇪 DE Taxable | 26.375% | 10.54% | 7.74% | $1,054 / yr |
| 🇫🇷 FR Taxable | 30% | 10.02% | 7.22% | $1,002 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 EYPT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 EYPT Dividend Payment Schedule
EYPT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 EYPT vs Healthcare Benchmarks
How EYPT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EYPT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ EYPT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-07-10 | 16,667 | — | — | ||
| F-InKind | 2026-07-10 | 8,059 | $14.72 | $118.6K | ||
| M-Exempt | 2026-07-10 | 16,667 | — | — | ||
| M-Exempt | 2026-06-30 | 2,437 | $8.26 | $20.1K | ||
| M-Exempt | 2026-06-30 | 2,438 | $8.26 | $20.1K | ||
| M-Exempt | 2026-06-30 | 2,438 | $8.26 | $20.1K | ||
| Sale | 2026-06-30 | 2,437 | $15.00 | $36.6K | ||
| M-Exempt | 2026-06-30 | 2,437 | $8.26 | $20.1K | ||
| Sale | 2026-06-30 | 2,438 | $15.02 | $36.6K | ||
| M-Exempt | 2026-05-25 | 7,500 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where EYPT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EYPT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
EyePoint Pharmaceuticals, Inc. (EYPT) is currently trading at $13.98, 51% below its 52-week high. The current dividend yield is 14.31% based on an annual payout of $2.00 per share.
EYPT (EyePoint Pharmaceuticals, Inc.) — 14.31% Dividend Yield Analysis
EyePoint Pharmaceuticals, Inc. (EYPT) is a healthcare stock currently trading at $13.98 with a dividend yield of 14.31%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (14.31%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.